Skip to main content

Animations

MJFF Publications

3241 - 3250 of 8571 Results
Title
Year
  • Year
  • 2016
  • 2019
  • 2021
  • 2025
  • 2022
  • 2015
  • 2018
  • 2022
  • 2025
  • 2020
  • Summary Details
    OPEN
    Title: Inflammatory profile in LRRK2-associated prodromal and clinical PD
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-016-0588-5
    Citation Count: 66
  • Summary Details
    OPEN
    Title: SNCAandmTORPathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27770
    Citation Count: 24
  • Summary Details
    OPEN
    Title: T-cell based immunotherapies for Parkinson’s disease
    Journal Name: Exploration of Neuroprotective Therapy
    Publisher: Open Exploration Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.37349/ent.2021.00007
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Tet2 loss and enhanced ciliogenesis suppress α-synuclein pathology
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s40478-025-01988-z
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Longitudinal IgG antibody responses to Plasmodium vivax blood-stage antigens during and after acute vivax malaria in individuals living in the Brazilian Amazon
    Journal Name: PLOS Neglected Tropical Diseases
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc0, cc0, cc0
    DOI - Digital Object Identifier: 10.1371/journal.pntd.0010773
    Citation Count: 7
  • Summary Details
    OPEN
    Title: High-content analysis of α-synuclein aggregation and cell death in a cellular model of Parkinson's disease
    Journal Name: Journal of Neuroscience Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jneumeth.2015.11.009
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: LRRK2‐mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27601
    Best OA location URL:
    Citation Count: 96
  • Summary Details
    OPEN
    Title: CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.834580
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Mapping cerebral blood perfusion and its links to multi-scale brain organization across the human lifespan
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3003277
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28056
    Best OA location URL:
    Citation Count: 46
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.